Skip to main content
Ju Fu Tang Biotech Holdings Co., Ltd logo

Ju Fu Tang Biotech Holdings Co., Ltd — Investor Relations & Filings

Ticker · 8217 ISIN · KYG5700C1244 HKEX Construction
Open in API
Filings indexed 413 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country HK Hong Kong
Listing HKEX 8217

About Ju Fu Tang Biotech Holdings Co., Ltd

https://www.todayir.com

Ju Fu Tang Biotech Holdings Co., Ltd. is an investment holding company primarily engaged in the provision of civil engineering services. The company's core operational focus includes the execution of civil engineering works, encompassing the construction and maintenance of transportation infrastructure such as roads and bridges. Furthermore, the company offers specialized decoration and renovation services. The entity operates as a provider of comprehensive construction and engineering solutions.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Regulatory Filings Classification · 91% confidence The document is a Monthly Return filed with Hong Kong Exchanges and Clearing Limited under Chapter 19B of the Exchange Listing Rules, detailing movements in authorised share capital, issued shares, treasury shares, share options, and public float confirmation. It is a recurring regulatory compliance submission rather than an earnings release, annual/interim report, management presentation, or capital transaction announcement. It does not contain substantive financial statements or raise capital; instead, it fulfills ongoing listing rule requirements. Therefore, it falls under the general category of Regulatory Filings (RNS).
2026-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filing to the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for Ju Fu Tang Biotech Holdings Co., Ltd for the month ended 30 April 2026. It details movements in authorized share capital, issued shares, share options, and confirms compliance with listing rules and regulatory requirements. The document is a regulatory submission reporting share capital and shareholding movements, not a financial report, earnings release, or management discussion. It is not an announcement of voting results, nor a capital raising update, but a routine regulatory filing about share capital and public float sufficiency. The document is over 10,000 characters and contains detailed data, so it is not a brief announcement or report publication notice. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2026-05-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings Classification · 90% confidence The document is a Hong Kong Stock Exchange form FF301 "Monthly Return for Equity Issuer and Hong Kong Depositary Receipts" showing movements in share capital, issued and treasury shares, share options, and public float confirmation for the month ended 31 March 2026. It is a routine regulatory filing to HKEX under Chapter 19B of the Listing Rules, and does not constitute an annual or interim report, earnings release, capital raising notice, dividend announcement, M&A activity, or any other specific category. It therefore falls into the general regulatory filings fallback category (RNS).
2026-04-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Regulatory Filings Classification · 95% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and share options. Since it is a recurring regulatory filing regarding share capital and securities movements that does not fit into specific categories like 'Share Issue' (which usually refers to a specific event) or 'Director's Dealing', it is classified as a Regulatory Filing.
2026-03-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Share Issue/Capital Change Classification · 95% confidence The document is a 'Monthly Return for Equity Issuer' filed with the Hong Kong Exchanges and Clearing Limited (HKEX). This is a standard regulatory filing required by the HKEX Listing Rules for companies to report monthly movements in their securities, share capital, and share options. It does not fit into specific categories like 'Annual Report' or 'Earnings Release' but is a mandatory regulatory disclosure, making 'RNS' (Regulatory Filings) the most appropriate classification.
2026-02-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Share Issue/Capital Change Classification · 95% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies to report monthly movements in securities, share capital, and treasury shares. Since it is a recurring regulatory filing mandated by the Exchange Listing Rules and does not fit into specific categories like 'Share Issue' (which is for specific events) or 'Annual Report', it is best classified as a Regulatory Filing (RNS).
2026-01-05 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.